Infertile Females or Females With Ovarian Insufficiency
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: Female
Age: 18 - 45
Code: NCT01870752
Recruiting
Improving Search Strategy for Identifying Urgent Conditions on the Chest X-ray
for
Using Expert Visual Search Strategy to Train Students to Read the Chest X-ray,
Location: Montreal
Sponsor: Université de Montréal
Sex: All
Age: 0+
Code: NCT01883570
Phase3, Recruiting
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
for
Ehlers-Danlos Syndrome, Pain, Chronic
Location: Old Westbury NY
Sponsor: New York Institute of Technology
Sex: All
Age: 18+
Code: NCT05561270
Recruiting
Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia
for
Parosmia
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18 - 70
Code: NCT06055270
Phase3, Recruiting
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
for
Babesiosis
Location: Boston MA
Sponsor: 60 Degrees Pharmaceuticals LLC
Sex: All
Age: 18+
Code: NCT06207370
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study
for
Liver Cirrhosis and Acute Kidney Injury
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18+
Code: NCT02147470
Recruiting
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
for
Interstitial Lung Disease, Common Variable Immunodeficiency
Location: Burlington MA, Durham NC, Tampa FL, Cincinnati OH,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 4+
Code: NCT04925375
Phase2, Recruiting
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: San Diego CA, Los Angeles CA, Davis CA,
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06252675
Phase2, Recruiting
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations